‘Proof of market’ to improve valorisation and commercialisation of Horizon generated R&I results (IA)[E8]
UnknownEuropean Commission[E1]
Em palavras simples
- O que financia
- Call: INDUSTRY. Type of action: HORIZON Innovation Actions. Expected Outcome: The commercial potential of Horizon research results is explored; Results of Horizon projects are valorised, by ensuring a pathway to commercialisation; and Startups and SMEs become involved in valorisation.
- Quem pode se inscrever
- EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.
- Aberto a: Startups
- Aberto a: Small and medium firms
- Fase: Growth and scale-up
- Datas
- Abre em 13 de out. de 2026.Fecha:Prazo do financiador: 2 de fev. de 2027, 01:00 Horário da Europa Central (UTC+1). UTC: 2 de fev. de 2027, 00:00 UTC.
- Financiamento
- EUR 12.500.000 no totalTipo de recurso: Grant.
- Financiador
- European CommissionVeja o que mais este financiador oferece.
- Como participar
- Inscreva-se diretamente com o financiador. Abrir a página do financiador em EU Funding & Tenders Portal (grants and calls for proposals) (abre em nova aba) ↗
- Edital e inscrição
O edital, as regras e o formulário de inscrição estão na página do financiador. Leia antes de se inscrever.
Financiador
O que mais este financiador ofereceEuropean Commission
A chamada não dá outro canal de contato com o financiador além da página original.
Como fazer uma pergunta
Envie perguntas pela página ou pelo canal de atendimento do financiador. Leia o guia primeiro. Abrir o canal do comprador
Mostramos apenas o canal de contato da própria organização como publicado: site, portal, caixas compartilhadas e telefone principal. Nunca uma pessoa.
- Abre[E6]
- 13 de out. de 2026
- Fecha[E2]
- 2 de fev. de 2027, 01:00 Horário da Europa Central (UTC+1)
- Financiamento total[E9]
- EUR 12.500.000
- Por proponente
- Não informado
- Última conferência
- há 9 horas
Sobre o financiamento
Do aviso
Call: INDUSTRY. Type of action: HORIZON Innovation Actions. Expected Outcome: The commercial potential of Horizon research results is explored; Results of Horizon projects are valorised, by ensuring a pathway to commercialisation; and Startups and SMEs become involved in valorisation. Scope: The EU must do better in translating the knowledge generated by the Framework Programme into innovations with economic and societal value. The objective of this action is to provide financial support (‘Proof of market’) to small consortia (i.e. spin-offs, startups, SMEs) to explore the exploitation potential, in the EU, of achieved results from ongoing or completed projects funded under Cluster 4 ‘Digital, Industry and Space’ or its predecessor activities under the Leadership in enabling and industrial technologies (LEIT) [1] part of Horizon 2020. The consortia do not necessarily have to be made of former or current beneficiaries but should own or have access to the knowledge assets of projects, including intellectual property, where relevant. Proposals should envisage valorisation activities, such as: demonstrating a technology (e.g. testing); defining a commercialisation process; undertaking: a market and competitiveness analysis; a technology assessment and/or certification; a verification of innovation potential; assessing potential “end users” of the expected innovation; testing, piloting with users or potential customers; complying with regulatory compliance and standards; consolidating IP rights. Proposals should address achieved results from ongoing or completed Research and Inn…[E3]
Quem pode se inscrever
Os detalhes do aviso aparecem como a fonte publicou. Os fatos e requisitos que extraímos estão em inglês.
- Aberto aStartups, Small and medium firms. Classificado pelo SLETOR a partir das palavras do edital.
- CondiçãoEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]
Riscos e incertezas
- RiscoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
- DesconhecidoWe read the funder's listing, not the full guidance or application forms.
Atualizações
Vista pela primeira vez · 28 de out. de 2026, 21:22 UTC
The funder published the call with a future closing date.
Registro de origem: ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49)
Evidências
9 dadosCada dado desta página vem do edital do financiador. Cada item mostra o registro e o campo de onde foi lido.
- E1
The funder is European Commission.
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/type/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
- E2
Proposals must be submitted by 2 Feb 2027, 01:00 Central European time (UTC+1).
“2027-02-02T00:00:00.000+0000”
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/deadlineDate/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
- E3
The buyer describes the requirement in the notice.
“Expected Outcome: The commercial potential of Horizon research results is explored; Results of Horizon projects are valorised, by ensuring a pathway to commercialisation; and Startups and SMEs become involved in valorisation. Scope: The EU must do better in translating the knowl…”
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/descriptionByte/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
- E4
EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.
“EU call topic”
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/type/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
- E5
This is an EU call for proposals.
“31094502”
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/status/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
- E6
Applications open on 13 Oct 2026.
“2026-10-13T00:00:00.000+0000”
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/startDate/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
- E7
The Funding & Tenders Portal gives the status as open for submission.
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/status/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
- E8
The notice is titled "‘Proof of market’ to improve valorisation and commercialisation of Horizon generated R&I results (IA)".
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/title/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
- E9
The EU contribution per grant is up to EUR 12,500,000 (from EUR 200,000).
De ‘Proof of market’ to improve valorisation and commercialisation of Horizon gene… (ID HORIZON-CL4-2027-01-MAT-PROD-49), campo /metadata/budgetOverview/0, lido 28 de out. de 2026, 21:22 UTC · fonte (abre em nova aba)
Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Licença dos dados: Creative Commons Attribution 4.0 (European Commission) (abre em nova aba). Dados de contato pessoais dos avisos não são guardados nem exibidos.